(-0.06%) 5 466.10 points
(-0.39%) 38 958 points
(0.28%) 17 767 points
(0.24%) $81.02
(-3.23%) $2.67
(-0.93%) $2 309.20
(-0.41%) $28.75
(1.54%) $1 001.60
(0.30%) $0.936
(0.78%) $10.69
(0.38%) $0.791
(-0.13%) $87.38
5 days till quarter result
(bmo 2024-07-01)
Expected move: +/- 4.92%
Live Chart Being Loaded With Signals
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans...
Stats | |
---|---|
本日の出来高 | 56 825 |
平均出来高 | 194 777 |
時価総額 | 195.42M |
次の収益日 | ( $-0.300 ) 2024-07-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0430 (1.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-06 | Bessemer Venture Partners Vii L.p. | Buy | 4 770 901 | Common Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 3 161 709 | Series B Preferred Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 2 236 537 | Series C-1 Preferred Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 1 953 271 | Series A Preferred Stock |
2024-02-06 | Bessemer Venture Partners Vii L.p. | Sell | 1 625 698 | Series C-2 Preferred Stock |
INSIDER POWER |
---|
-32.74 |
Last 41 transactions |
Buy: 15 629 342 | Sell: 30 947 547 |
ボリューム 相関
Fractyl Health, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Fractyl Health, Inc. 相関 - 通貨/商品
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Fractyl Health, Inc.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。